Skip to main content

Myeloproliferative Neoplasms Specialty Channel

Featured Article
Which of the following has been linked to poorer outcomes in patients with myelodysplastic syndromes?
Intensive chemotherapy may be more effective than alternative treatment for younger patients with myelodysplastic syndromes.
Many patients with myeloproliferative neoplasms experience a negative impact on work productivity and employment after diagnosis, according to a…
Expert Insights
Ayalew Tefferi, MD, talks about the revised MIPSS version 2.0 and what it means for the future of primary myelofibrosis.
The Congress co-chairs highlight the key points presented during the meeting, with the aim of sharing updates that will help you enhance your…
Michael Mauro, MD, explains essential thrombocythemia and the future of treatment and management of the disease.
Angela G Fleischman, MD, discusses the role of inflammation in myeloproliferative neoplasm transition to leukemia.
Interactive Features
Which of the following has been linked to poorer outcomes in patients with myelodysplastic syndromes?
Within the past 3 months, the treatment landscapes for myeloproliferative neoplasms have been evolving, with multiple updates to procedures,…
This new interactive feature allows you to review the treatment options for low-risk primary myelofibrosis, share your approach to determining the…
Updated NCCN guidelines for myeloproliferative neoplasms offer which of the following options for the management of myelofibrosis-associated anemia?